Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis.
D000208:Acute Disease; D000818:Animals; D003711:Demyelinating Diseases / Q000473:pathology; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000188:drug therapy; D007294:Inositol / Q000032:analysis / Q000378:metabolism*; D007328:Insulin / Q000172:deficiency* / Q000494:pharmacology / Q000627:therapeutic use; D009431:Neural Conduction / Q000187:drug effects; D010525:Peripheral Nerves / Q000032:analysis; D051381:Rats
D007328:Insulin; D007294:Inositol